NLM Digital Collections

Search

Start Over Subjects Drug Costs -- trends ✖Remove constraint Subjects: Drug Costs -- trends Copyright Public domain ✖Remove constraint Copyright: Public domain

3. Rebates for brand-name drugs in Part D substantially reduced the growth in spending from 2011 to 2015

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, September 2019
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Insurance, Health, Reimbursement -- statistics & numerical data
Insurance, Health, Reimbursement -- trends
Medicare Part D -- economics
Medicare Part D -- statistics & numerical data
Medicare Part D -- trends
Economics, Pharmaceutical -- statistics & numerical data
Economics, Pharmaceutical -- trends
Forecasting
Prescription Drugs -- economics
Humans
United States

4. Changes in the list prices of prescription drugs, 2017-2023

Author(s):
Bosworth, Arielle, author
Sheingold, Steven, author
Finegold, Kenneth, author
Sayed, Bisma A., author
De Lew, Nancy, author
Sommers, Benjamin D., author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation, Office of Health Policy, October 6, 2023
Subject(s):
Drug Costs -- trends
Prescription Drugs -- economics
United States

5. Competition in prescription drug markets, 2017-2022

Author(s):
Parasrampuria, Sonal, author
Murphy, Stephen J. (Stephen James), author
Publication:
Washington, D.C. : Office of the Assistant Secretary for Planning and Evaluation (ASPE), U.S. Department of Health and Human Services, December 2023
Subject(s):
Drug Costs -- statistics & numerical data
Drug Costs -- trends
Economic Competition
Drug Industry -- economics
Drug Industry -- trends
Prescription Drugs -- economics
United States